Cleared Traditional

K851620 - SPIROMED 2

K851620 is an FDA 510(k) clearance for SPIROMED 2, manufactured by Draeger Medical, Inc.. The device is a Class 2 Anesthesiology device with product code BZG cleared through the Traditional 510(k) pathway after a 22-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1985
Decision
22d
Days
Class 2
Risk

K851620 is an FDA 510(k) clearance for the SPIROMED 2. Classified as Spirometer, Diagnostic (product code BZG), Class II - Special Controls.

Submitted by Draeger Medical, Inc. (Telford, US). The FDA issued a Cleared decision on May 10, 1985 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1840 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Draeger Medical, Inc. devices

FDA 510(k) Submission Details - K851620

510(k) Number K851620 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 1985
Decision Date May 10, 1985
Days to Decision 22 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 140d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZG Device Classification - Class 2, Special Controls

Product Code BZG Spirometer, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZG Spirometer, Diagnostic

All 49
Devices cleared under the same product code (BZG) and FDA review panel - the closest regulatory comparables to K851620.
PALL PULMONARY FUNCTION FILTER
K854062 · Pall Biomedical Products Co. · Nov 1985
PB900 PB910 DIAGNOSTIC SPIROMETER
K852092 · Puritan Bennett Corp. · Jul 1985
PNEUMOSCOPE
K852337 · Erich Jaeger, Inc. · Jul 1985
ERGO-OXYSCREEN
K843841 · Erich Jaeger, Inc. · Dec 1984
PULMONARY FUNCTION SYSTEM
K842041 · Sensor Medics Corp. · Jun 1984
RESPIRODYNE PULMONARY FUNCTION TEST
K834475 · Chesebrough-Pond'S U.S.A. Co. · Feb 1984